Allianz Asset Management’s Viking Therapeutics VKTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.91M | Sell |
72,002
-24,361
| -25% | -$646K | ﹤0.01% | 1122 |
|
|
2025
Q1 | $2.33M | Sell |
96,363
-35,986
| -27% | -$869K | ﹤0.01% | 1098 |
|
|
2024
Q4 | $5.33M | Buy |
132,349
+26,306
| +25% | +$1.06M | 0.01% | 849 |
|
|
2024
Q3 | $6.71M | Buy |
+106,043
| New | +$6.71M | 0.01% | 768 |
|
|
2024
Q2 | – | Sell |
-7,200
| Closed | -$590K | – | 1758 |
|
|
2024
Q1 | $590K | Buy |
+7,200
| New | +$590K | ﹤0.01% | 1375 |
|
|
2020
Q2 | – | Sell |
-87,125
| Closed | -$408K | – | 2041 |
|
|
2020
Q1 | $408K | Sell |
87,125
-1,259
| -1% | -$5.9K | ﹤0.01% | 1698 |
|
|
2019
Q4 | $709K | Buy |
88,384
+847
| +1% | +$6.79K | ﹤0.01% | 1820 |
|
|
2019
Q3 | $602K | Sell |
87,537
-128,533
| -59% | -$884K | ﹤0.01% | 1834 |
|
|
2019
Q2 | $1.79M | Buy |
216,070
+35,271
| +20% | +$293K | ﹤0.01% | 1573 |
|
|
2019
Q1 | $1.8M | Buy |
180,799
+13,006
| +8% | +$129K | ﹤0.01% | 1581 |
|
|
2018
Q4 | $1.28M | Buy |
167,793
+23,361
| +16% | +$179K | ﹤0.01% | 1604 |
|
|
2018
Q3 | $2.52M | Buy |
+144,432
| New | +$2.52M | ﹤0.01% | 1506 |
|